Δ 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture

Cannabinoids inhibit excitatory synaptic transmission between hippocampal neurons in culture. Δ 9-tetrahydrocannabinol (THC), the principal psychoactive component in marijuana, acts as a partial agonist at these synapses. Thus, THC inhibited but did not block synaptic transmission when applied alone...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropharmacology 2004-04, Vol.46 (5), p.709-715
Hauptverfasser: Kelley, Brooke G., Thayer, Stanley A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 715
container_issue 5
container_start_page 709
container_title Neuropharmacology
container_volume 46
creator Kelley, Brooke G.
Thayer, Stanley A.
description Cannabinoids inhibit excitatory synaptic transmission between hippocampal neurons in culture. Δ 9-tetrahydrocannabinol (THC), the principal psychoactive component in marijuana, acts as a partial agonist at these synapses. Thus, THC inhibited but did not block synaptic transmission when applied alone and, when applied in combination with WIN552212-2, it partially reversed the effects of this full agonist. Here, we address the question of how THC might interact with endocannabinoid signaling. Reducing the extracellular Mg 2+ concentration to 0.1 mM elicited a repetitive pattern of glutamatergic synaptic activity that produced intracellular Ca 2+ concentration spikes that were measured by indo-1-based microfluorimetry. The endocannabinoid, 2-arachidonyl glycerol (2-AG) produced a concentration-dependent and complete inhibition of spike frequency with an EC 50 of 63±13 nM. 2-AG (1 μM) inhibition of spiking was blocked by SR141716A (1 μM). THC (100 nM) antagonized the actions of 2-AG producing a parallel shift in the concentration–response relationship for 2-AG (EC 50 of 1430±254 nM). The attenuation of 2-AG (1 μM) inhibition of synaptic activity by THC was concentration-dependent with an IC 50 of 42±9 nM. These results demonstrate that THC can antagonize endocannabinoid signaling. Thus, the effects of THC on synaptic transmission are predicted to depend on the level of endocannabinoid tone.
doi_str_mv 10.1016/j.neuropharm.2003.11.005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71700846</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390803004258</els_id><sourcerecordid>71700846</sourcerecordid><originalsourceid>FETCH-LOGICAL-e1138-2e082db4657885fd51a47334cad99039a70a18c02588e2c53609211e307056f43</originalsourceid><addsrcrecordid>eNpFkc9O3DAQhy1UBMufV6h86i3pTOwkzrFFLVRC6gXOlteeZb1K7NROWi0nHqLP1WciW0Cc5vD7ZvTTfIxxhBIBm8-7MtCc4rg1aSgrAFEilgD1EVuhakXRQiM_sBVApQrRgTplZznvAEAqVCfsFGXXNbVUK_b07y_vijuaktnuXYrWhGDWPsSemzCZhxj8I2VOwb1H3vEhurk3k4-Bxw3P-2DGyVu-XAl58DkfgjVNf4gC3_pxXJaH0fT8f-2QuQ_czv00J7pgxxvTZ7p8nefs_vu3u6ub4vbn9Y-rL7cFIQpVVASqcmvZ1K1S9cbVaGQrhLTGdR2IzrRgUFmoaqWosrVooKsQSUALdbOR4px9erk7pvhrpjzppaelvjeB4px1iy2Aks0CfnwF5_VATo_JDybt9dvPFuDrC0BL3d-eks7WU7DkfCI7aRe9RtAHUXqn30XpgyiNqBdR4hnTsYvY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71700846</pqid></control><display><type>article</type><title>Δ 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kelley, Brooke G. ; Thayer, Stanley A.</creator><creatorcontrib>Kelley, Brooke G. ; Thayer, Stanley A.</creatorcontrib><description>Cannabinoids inhibit excitatory synaptic transmission between hippocampal neurons in culture. Δ 9-tetrahydrocannabinol (THC), the principal psychoactive component in marijuana, acts as a partial agonist at these synapses. Thus, THC inhibited but did not block synaptic transmission when applied alone and, when applied in combination with WIN552212-2, it partially reversed the effects of this full agonist. Here, we address the question of how THC might interact with endocannabinoid signaling. Reducing the extracellular Mg 2+ concentration to 0.1 mM elicited a repetitive pattern of glutamatergic synaptic activity that produced intracellular Ca 2+ concentration spikes that were measured by indo-1-based microfluorimetry. The endocannabinoid, 2-arachidonyl glycerol (2-AG) produced a concentration-dependent and complete inhibition of spike frequency with an EC 50 of 63±13 nM. 2-AG (1 μM) inhibition of spiking was blocked by SR141716A (1 μM). THC (100 nM) antagonized the actions of 2-AG producing a parallel shift in the concentration–response relationship for 2-AG (EC 50 of 1430±254 nM). The attenuation of 2-AG (1 μM) inhibition of synaptic activity by THC was concentration-dependent with an IC 50 of 42±9 nM. These results demonstrate that THC can antagonize endocannabinoid signaling. Thus, the effects of THC on synaptic transmission are predicted to depend on the level of endocannabinoid tone.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2003.11.005</identifier><identifier>PMID: 14996548</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>2-Arachidonyl glycerol ; Animals ; Cannabinoid ; Cannabinoid Receptor Modulators - antagonists &amp; inhibitors ; Cannabinoid Receptor Modulators - pharmacology ; CB1 ; Cells, Cultured ; Dose-Response Relationship, Drug ; Dronabinol - pharmacology ; Endocannabinoids ; Excitatory synaptic transmission ; Female ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - physiology ; Neurons - drug effects ; Neurons - physiology ; Pregnancy ; Rats ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology ; Tetrahydrocannabinol</subject><ispartof>Neuropharmacology, 2004-04, Vol.46 (5), p.709-715</ispartof><rights>2004 Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuropharm.2003.11.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14996548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kelley, Brooke G.</creatorcontrib><creatorcontrib>Thayer, Stanley A.</creatorcontrib><title>Δ 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Cannabinoids inhibit excitatory synaptic transmission between hippocampal neurons in culture. Δ 9-tetrahydrocannabinol (THC), the principal psychoactive component in marijuana, acts as a partial agonist at these synapses. Thus, THC inhibited but did not block synaptic transmission when applied alone and, when applied in combination with WIN552212-2, it partially reversed the effects of this full agonist. Here, we address the question of how THC might interact with endocannabinoid signaling. Reducing the extracellular Mg 2+ concentration to 0.1 mM elicited a repetitive pattern of glutamatergic synaptic activity that produced intracellular Ca 2+ concentration spikes that were measured by indo-1-based microfluorimetry. The endocannabinoid, 2-arachidonyl glycerol (2-AG) produced a concentration-dependent and complete inhibition of spike frequency with an EC 50 of 63±13 nM. 2-AG (1 μM) inhibition of spiking was blocked by SR141716A (1 μM). THC (100 nM) antagonized the actions of 2-AG producing a parallel shift in the concentration–response relationship for 2-AG (EC 50 of 1430±254 nM). The attenuation of 2-AG (1 μM) inhibition of synaptic activity by THC was concentration-dependent with an IC 50 of 42±9 nM. These results demonstrate that THC can antagonize endocannabinoid signaling. Thus, the effects of THC on synaptic transmission are predicted to depend on the level of endocannabinoid tone.</description><subject>2-Arachidonyl glycerol</subject><subject>Animals</subject><subject>Cannabinoid</subject><subject>Cannabinoid Receptor Modulators - antagonists &amp; inhibitors</subject><subject>Cannabinoid Receptor Modulators - pharmacology</subject><subject>CB1</subject><subject>Cells, Cultured</subject><subject>Dose-Response Relationship, Drug</subject><subject>Dronabinol - pharmacology</subject><subject>Endocannabinoids</subject><subject>Excitatory synaptic transmission</subject><subject>Female</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - physiology</subject><subject>Neurons - drug effects</subject><subject>Neurons - physiology</subject><subject>Pregnancy</subject><subject>Rats</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><subject>Tetrahydrocannabinol</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc9O3DAQhy1UBMufV6h86i3pTOwkzrFFLVRC6gXOlteeZb1K7NROWi0nHqLP1WciW0Cc5vD7ZvTTfIxxhBIBm8-7MtCc4rg1aSgrAFEilgD1EVuhakXRQiM_sBVApQrRgTplZznvAEAqVCfsFGXXNbVUK_b07y_vijuaktnuXYrWhGDWPsSemzCZhxj8I2VOwb1H3vEhurk3k4-Bxw3P-2DGyVu-XAl58DkfgjVNf4gC3_pxXJaH0fT8f-2QuQ_czv00J7pgxxvTZ7p8nefs_vu3u6ub4vbn9Y-rL7cFIQpVVASqcmvZ1K1S9cbVaGQrhLTGdR2IzrRgUFmoaqWosrVooKsQSUALdbOR4px9erk7pvhrpjzppaelvjeB4px1iy2Aks0CfnwF5_VATo_JDybt9dvPFuDrC0BL3d-eks7WU7DkfCI7aRe9RtAHUXqn30XpgyiNqBdR4hnTsYvY</recordid><startdate>200404</startdate><enddate>200404</enddate><creator>Kelley, Brooke G.</creator><creator>Thayer, Stanley A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200404</creationdate><title>Δ 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture</title><author>Kelley, Brooke G. ; Thayer, Stanley A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e1138-2e082db4657885fd51a47334cad99039a70a18c02588e2c53609211e307056f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>2-Arachidonyl glycerol</topic><topic>Animals</topic><topic>Cannabinoid</topic><topic>Cannabinoid Receptor Modulators - antagonists &amp; inhibitors</topic><topic>Cannabinoid Receptor Modulators - pharmacology</topic><topic>CB1</topic><topic>Cells, Cultured</topic><topic>Dose-Response Relationship, Drug</topic><topic>Dronabinol - pharmacology</topic><topic>Endocannabinoids</topic><topic>Excitatory synaptic transmission</topic><topic>Female</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - physiology</topic><topic>Neurons - drug effects</topic><topic>Neurons - physiology</topic><topic>Pregnancy</topic><topic>Rats</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><topic>Tetrahydrocannabinol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kelley, Brooke G.</creatorcontrib><creatorcontrib>Thayer, Stanley A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kelley, Brooke G.</au><au>Thayer, Stanley A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Δ 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2004-04</date><risdate>2004</risdate><volume>46</volume><issue>5</issue><spage>709</spage><epage>715</epage><pages>709-715</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>Cannabinoids inhibit excitatory synaptic transmission between hippocampal neurons in culture. Δ 9-tetrahydrocannabinol (THC), the principal psychoactive component in marijuana, acts as a partial agonist at these synapses. Thus, THC inhibited but did not block synaptic transmission when applied alone and, when applied in combination with WIN552212-2, it partially reversed the effects of this full agonist. Here, we address the question of how THC might interact with endocannabinoid signaling. Reducing the extracellular Mg 2+ concentration to 0.1 mM elicited a repetitive pattern of glutamatergic synaptic activity that produced intracellular Ca 2+ concentration spikes that were measured by indo-1-based microfluorimetry. The endocannabinoid, 2-arachidonyl glycerol (2-AG) produced a concentration-dependent and complete inhibition of spike frequency with an EC 50 of 63±13 nM. 2-AG (1 μM) inhibition of spiking was blocked by SR141716A (1 μM). THC (100 nM) antagonized the actions of 2-AG producing a parallel shift in the concentration–response relationship for 2-AG (EC 50 of 1430±254 nM). The attenuation of 2-AG (1 μM) inhibition of synaptic activity by THC was concentration-dependent with an IC 50 of 42±9 nM. These results demonstrate that THC can antagonize endocannabinoid signaling. Thus, the effects of THC on synaptic transmission are predicted to depend on the level of endocannabinoid tone.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>14996548</pmid><doi>10.1016/j.neuropharm.2003.11.005</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 2004-04, Vol.46 (5), p.709-715
issn 0028-3908
1873-7064
language eng
recordid cdi_proquest_miscellaneous_71700846
source MEDLINE; Elsevier ScienceDirect Journals
subjects 2-Arachidonyl glycerol
Animals
Cannabinoid
Cannabinoid Receptor Modulators - antagonists & inhibitors
Cannabinoid Receptor Modulators - pharmacology
CB1
Cells, Cultured
Dose-Response Relationship, Drug
Dronabinol - pharmacology
Endocannabinoids
Excitatory synaptic transmission
Female
Hippocampus
Hippocampus - drug effects
Hippocampus - physiology
Neurons - drug effects
Neurons - physiology
Pregnancy
Rats
Synaptic Transmission - drug effects
Synaptic Transmission - physiology
Tetrahydrocannabinol
title Δ 9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A37%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%94%209-Tetrahydrocannabinol%20antagonizes%20endocannabinoid%20modulation%20of%20synaptic%20transmission%20between%20hippocampal%20neurons%20in%20culture&rft.jtitle=Neuropharmacology&rft.au=Kelley,%20Brooke%20G.&rft.date=2004-04&rft.volume=46&rft.issue=5&rft.spage=709&rft.epage=715&rft.pages=709-715&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2003.11.005&rft_dat=%3Cproquest_pubme%3E71700846%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71700846&rft_id=info:pmid/14996548&rft_els_id=S0028390803004258&rfr_iscdi=true